I like your idea of a share buyback program. They could and should do that with some of the coming revenues.
Just thinking out loud here. What if all is great with LymPro before the up list and then they decide to spinoff the diagnostics division to shareholders of record AFTER the up listing. That would get the AMBS stock price moving with a 2 company's for one purchase price.
Plus they have so many other wild cards it's hard to guess.